Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
IRCCS San Raffaele
Canadian Cancer Trials Group
University of Washington
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Duke University
Bio-Path Holdings, Inc.
St. Jude Children's Research Hospital
Pfizer
Aileron Therapeutics, Inc.
University of Maryland, Baltimore
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
St. Jude Children's Research Hospital
Barbara Ann Karmanos Cancer Institute
Hospital Israelita Albert Einstein
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Children's Oncology Group
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Baylor Research Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center